IBDEI0PP ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11552,1,3,0)
;;=3^Hyperkalemia
;;^UTILITY(U,$J,358.3,11552,1,4,0)
;;=4^E87.5
;;^UTILITY(U,$J,358.3,11552,2)
;;=^60041
;;^UTILITY(U,$J,358.3,11553,0)
;;=E87.6^^46^559^20
;;^UTILITY(U,$J,358.3,11553,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11553,1,3,0)
;;=3^Hypokalemia
;;^UTILITY(U,$J,358.3,11553,1,4,0)
;;=4^E87.6
;;^UTILITY(U,$J,358.3,11553,2)
;;=^60610
;;^UTILITY(U,$J,358.3,11554,0)
;;=E87.8^^46^559^8
;;^UTILITY(U,$J,358.3,11554,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11554,1,3,0)
;;=3^Electrolyte & Fluid Balance Disorders NEC
;;^UTILITY(U,$J,358.3,11554,1,4,0)
;;=4^E87.8
;;^UTILITY(U,$J,358.3,11554,2)
;;=^5003026
;;^UTILITY(U,$J,358.3,11555,0)
;;=E26.81^^46^559^5
;;^UTILITY(U,$J,358.3,11555,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11555,1,3,0)
;;=3^Bartter's Syndrome
;;^UTILITY(U,$J,358.3,11555,1,4,0)
;;=4^E26.81
;;^UTILITY(U,$J,358.3,11555,2)
;;=^329906
;;^UTILITY(U,$J,358.3,11556,0)
;;=E23.2^^46^559^7
;;^UTILITY(U,$J,358.3,11556,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11556,1,3,0)
;;=3^Diabetes Insipidus
;;^UTILITY(U,$J,358.3,11556,1,4,0)
;;=4^E23.2
;;^UTILITY(U,$J,358.3,11556,2)
;;=^33572
;;^UTILITY(U,$J,358.3,11557,0)
;;=E83.41^^46^559^15
;;^UTILITY(U,$J,358.3,11557,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11557,1,3,0)
;;=3^Hypermagnesemia
;;^UTILITY(U,$J,358.3,11557,1,4,0)
;;=4^E83.41
;;^UTILITY(U,$J,358.3,11557,2)
;;=^5003002
;;^UTILITY(U,$J,358.3,11558,0)
;;=E21.3^^46^559^17
;;^UTILITY(U,$J,358.3,11558,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11558,1,3,0)
;;=3^Hyperparathyroidism,Unspec
;;^UTILITY(U,$J,358.3,11558,1,4,0)
;;=4^E21.3
;;^UTILITY(U,$J,358.3,11558,2)
;;=^331438
;;^UTILITY(U,$J,358.3,11559,0)
;;=E83.42^^46^559^21
;;^UTILITY(U,$J,358.3,11559,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11559,1,3,0)
;;=3^Hypomagnesemia
;;^UTILITY(U,$J,358.3,11559,1,4,0)
;;=4^E83.42
;;^UTILITY(U,$J,358.3,11559,2)
;;=^5003003
;;^UTILITY(U,$J,358.3,11560,0)
;;=N25.1^^46^559^25
;;^UTILITY(U,$J,358.3,11560,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11560,1,3,0)
;;=3^Nephrogenic Diabetes Insipidus
;;^UTILITY(U,$J,358.3,11560,1,4,0)
;;=4^N25.1
;;^UTILITY(U,$J,358.3,11560,2)
;;=^5015616
;;^UTILITY(U,$J,358.3,11561,0)
;;=E27.49^^46^559^2
;;^UTILITY(U,$J,358.3,11561,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11561,1,3,0)
;;=3^Adrenocortical Insufficiency,Other
;;^UTILITY(U,$J,358.3,11561,1,4,0)
;;=4^E27.49
;;^UTILITY(U,$J,358.3,11561,2)
;;=^5002743
;;^UTILITY(U,$J,358.3,11562,0)
;;=E72.09^^46^559^4
;;^UTILITY(U,$J,358.3,11562,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11562,1,3,0)
;;=3^Amino-Acid Transport Disorders,Other
;;^UTILITY(U,$J,358.3,11562,1,4,0)
;;=4^E72.09
;;^UTILITY(U,$J,358.3,11562,2)
;;=^5002895
;;^UTILITY(U,$J,358.3,11563,0)
;;=N25.89^^46^559^23
;;^UTILITY(U,$J,358.3,11563,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11563,1,3,0)
;;=3^Impaired Renal Tubular Function Disorders,Other
;;^UTILITY(U,$J,358.3,11563,1,4,0)
;;=4^N25.89
;;^UTILITY(U,$J,358.3,11563,2)
;;=^5015618
;;^UTILITY(U,$J,358.3,11564,0)
;;=E26.89^^46^559^12
;;^UTILITY(U,$J,358.3,11564,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11564,1,3,0)
;;=3^Hyperaldosteronism,Other
;;^UTILITY(U,$J,358.3,11564,1,4,0)
;;=4^E26.89
;;^UTILITY(U,$J,358.3,11564,2)
;;=^5002737
;;^UTILITY(U,$J,358.3,11565,0)
;;=N25.81^^46^559^29
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0PP 3793 printed Sep 23, 2025@19:29:20 Page 2
IBDEI0PP ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11552,1,3,0)
+2 ;;=3^Hyperkalemia
+3 ;;^UTILITY(U,$J,358.3,11552,1,4,0)
+4 ;;=4^E87.5
+5 ;;^UTILITY(U,$J,358.3,11552,2)
+6 ;;=^60041
+7 ;;^UTILITY(U,$J,358.3,11553,0)
+8 ;;=E87.6^^46^559^20
+9 ;;^UTILITY(U,$J,358.3,11553,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,11553,1,3,0)
+12 ;;=3^Hypokalemia
+13 ;;^UTILITY(U,$J,358.3,11553,1,4,0)
+14 ;;=4^E87.6
+15 ;;^UTILITY(U,$J,358.3,11553,2)
+16 ;;=^60610
+17 ;;^UTILITY(U,$J,358.3,11554,0)
+18 ;;=E87.8^^46^559^8
+19 ;;^UTILITY(U,$J,358.3,11554,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,11554,1,3,0)
+22 ;;=3^Electrolyte & Fluid Balance Disorders NEC
+23 ;;^UTILITY(U,$J,358.3,11554,1,4,0)
+24 ;;=4^E87.8
+25 ;;^UTILITY(U,$J,358.3,11554,2)
+26 ;;=^5003026
+27 ;;^UTILITY(U,$J,358.3,11555,0)
+28 ;;=E26.81^^46^559^5
+29 ;;^UTILITY(U,$J,358.3,11555,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,11555,1,3,0)
+32 ;;=3^Bartter's Syndrome
+33 ;;^UTILITY(U,$J,358.3,11555,1,4,0)
+34 ;;=4^E26.81
+35 ;;^UTILITY(U,$J,358.3,11555,2)
+36 ;;=^329906
+37 ;;^UTILITY(U,$J,358.3,11556,0)
+38 ;;=E23.2^^46^559^7
+39 ;;^UTILITY(U,$J,358.3,11556,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,11556,1,3,0)
+42 ;;=3^Diabetes Insipidus
+43 ;;^UTILITY(U,$J,358.3,11556,1,4,0)
+44 ;;=4^E23.2
+45 ;;^UTILITY(U,$J,358.3,11556,2)
+46 ;;=^33572
+47 ;;^UTILITY(U,$J,358.3,11557,0)
+48 ;;=E83.41^^46^559^15
+49 ;;^UTILITY(U,$J,358.3,11557,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,11557,1,3,0)
+52 ;;=3^Hypermagnesemia
+53 ;;^UTILITY(U,$J,358.3,11557,1,4,0)
+54 ;;=4^E83.41
+55 ;;^UTILITY(U,$J,358.3,11557,2)
+56 ;;=^5003002
+57 ;;^UTILITY(U,$J,358.3,11558,0)
+58 ;;=E21.3^^46^559^17
+59 ;;^UTILITY(U,$J,358.3,11558,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,11558,1,3,0)
+62 ;;=3^Hyperparathyroidism,Unspec
+63 ;;^UTILITY(U,$J,358.3,11558,1,4,0)
+64 ;;=4^E21.3
+65 ;;^UTILITY(U,$J,358.3,11558,2)
+66 ;;=^331438
+67 ;;^UTILITY(U,$J,358.3,11559,0)
+68 ;;=E83.42^^46^559^21
+69 ;;^UTILITY(U,$J,358.3,11559,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,11559,1,3,0)
+72 ;;=3^Hypomagnesemia
+73 ;;^UTILITY(U,$J,358.3,11559,1,4,0)
+74 ;;=4^E83.42
+75 ;;^UTILITY(U,$J,358.3,11559,2)
+76 ;;=^5003003
+77 ;;^UTILITY(U,$J,358.3,11560,0)
+78 ;;=N25.1^^46^559^25
+79 ;;^UTILITY(U,$J,358.3,11560,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,11560,1,3,0)
+82 ;;=3^Nephrogenic Diabetes Insipidus
+83 ;;^UTILITY(U,$J,358.3,11560,1,4,0)
+84 ;;=4^N25.1
+85 ;;^UTILITY(U,$J,358.3,11560,2)
+86 ;;=^5015616
+87 ;;^UTILITY(U,$J,358.3,11561,0)
+88 ;;=E27.49^^46^559^2
+89 ;;^UTILITY(U,$J,358.3,11561,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,11561,1,3,0)
+92 ;;=3^Adrenocortical Insufficiency,Other
+93 ;;^UTILITY(U,$J,358.3,11561,1,4,0)
+94 ;;=4^E27.49
+95 ;;^UTILITY(U,$J,358.3,11561,2)
+96 ;;=^5002743
+97 ;;^UTILITY(U,$J,358.3,11562,0)
+98 ;;=E72.09^^46^559^4
+99 ;;^UTILITY(U,$J,358.3,11562,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,11562,1,3,0)
+102 ;;=3^Amino-Acid Transport Disorders,Other
+103 ;;^UTILITY(U,$J,358.3,11562,1,4,0)
+104 ;;=4^E72.09
+105 ;;^UTILITY(U,$J,358.3,11562,2)
+106 ;;=^5002895
+107 ;;^UTILITY(U,$J,358.3,11563,0)
+108 ;;=N25.89^^46^559^23
+109 ;;^UTILITY(U,$J,358.3,11563,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,11563,1,3,0)
+112 ;;=3^Impaired Renal Tubular Function Disorders,Other
+113 ;;^UTILITY(U,$J,358.3,11563,1,4,0)
+114 ;;=4^N25.89
+115 ;;^UTILITY(U,$J,358.3,11563,2)
+116 ;;=^5015618
+117 ;;^UTILITY(U,$J,358.3,11564,0)
+118 ;;=E26.89^^46^559^12
+119 ;;^UTILITY(U,$J,358.3,11564,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,11564,1,3,0)
+122 ;;=3^Hyperaldosteronism,Other
+123 ;;^UTILITY(U,$J,358.3,11564,1,4,0)
+124 ;;=4^E26.89
+125 ;;^UTILITY(U,$J,358.3,11564,2)
+126 ;;=^5002737
+127 ;;^UTILITY(U,$J,358.3,11565,0)
+128 ;;=N25.81^^46^559^29
